Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Doxycycline plus probiotics for rosacea
ChiCTR2300073060Phase 4Not yet recruiting
- Sponsor
- Xiangya Hospital, Central South University
- Start
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of doxycycline in rosacea (3 arms), sponsored by Xiangya Hospital, Central South University. Primary endpoints: Rosacea clinical symptom severity assessment (physician assessment) and Rosacea clinical symptom severity assessment (patient assessment). Planned start Jun 2023; status: not yet recruiting.
02
Drugs
doxycycline
03
Conditions
rosacea
Beyond the preview
Go deeper on ChiCTR2300073060.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300073060.